Dr. Anders Nattestad is a San Francisco, California based Oral and Maxillofacial Surgeon who is specialized in Oral and Maxillofacial Surgery. He may accept the Medicare-approved amount. Patients may be billed for more than the Medicare deductible and coinsurance. His current practice location is 155 5th St, Suite 350, San Francisco. Patients can reach him at 415-351-7191.
Dr. Anders Nattestad deals with the diagnosis, surgical and adjunctive treatment of diseases, injuries and defects involving both the functional and esthetic aspects of the hard and soft tissues of the oral and maxillofacial region.
Complete Profile:
Dr. Anders Nattestad speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Name:
Dr. Anders Nattestad
Specialization:
Oral and Maxillofacial Surgeon
Gender:
Male
Credentials:
DDS, PH.D.
Accepts Medicare Assignment:
May Accept
Practice Address:
155 5th St, Suite 350, San Francisco, California, 94103-2919
Phone:
415-351-7191
Fax:
415-749-3339
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
PAC ID:
7719118843
Enrollment ID:
I20140402001502
NPI Number:
1386786606
NPI Enumeration Date:
13 Feb, 2007
NPI Last Update On:
16 Jun, 2014
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
155 5th St, Suite 350 San Francisco, California
Zip:
94103-2919
Phone Number:
415-351-7191
Fax Number:
415-749-3339
Patients can reach Dr. Anders Nattestad at 155 5th St, Suite 350, San Francisco, California or can call to book an appointment on 415-351-7191. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 14 October, 2024.